These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1190920)

  • 1. Effects of L-dopa on myocardial contractile force: a reappraisal.
    Wenger JJ; Osborne MW
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):251-6. PubMed ID: 1190920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cardiac effects of ASI-222 HCl, an aminosugar cardiac glycoside, and digoxin.
    Cook LS; Caldwell RW; Nash CB
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):220-32. PubMed ID: 907408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
    Osborne MW; Wenger JJ; Willems W
    J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats.
    Watanabe AM; Judy WV; Cardon PV
    J Pharmacol Exp Ther; 1974 Jan; 188(1):107-13. PubMed ID: 4809262
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.
    Wilke WL
    Pediatr Res; 1983 Nov; 17(11):924-5. PubMed ID: 6359046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC; Roebel LE; Hsieh CP; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular pharmacology of the antibiotic ionophore Ro 2-2985 (X537A).
    Osborne MW; Wenger JJ; Zanko MT
    J Pharmacol Exp Ther; 1977 Jan; 200(1):195-206. PubMed ID: 833757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-dopa: its effect on the cardiovascular system.
    Carrasco HA; Lozano J; Lang TW; Meerbaum S
    Geriatrics; 1971 Sep; 26(9):100-8. PubMed ID: 5125691
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of an antispastic, analgesic combination on blood pressure, dynamics and contractility of the left ventricle in the dog].
    Komarek J
    Arzneimittelforschung; 1976; 26(8):1583-8. PubMed ID: 1036957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of halothane, sevoflurane and desflurane on the force-frequency relation in the dog heart in vivo.
    Preckel B; Obal D; Müllenheim J; Hennes J; Heiderhoff M; Thämer V; Schlack W
    Can J Anaesth; 2006 Nov; 53(11):1118-25. PubMed ID: 17079640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of xylazine on indices of myocardial contractility in the dog.
    Muir WW; Piper FS
    Am J Vet Res; 1977 Jul; 38(7):931-4. PubMed ID: 883719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
    Antonaccio MJ; Robson RD
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):89-102. PubMed ID: 4281293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of amantadine on heart and circulation].
    van Ackern K; Deuster JE; Mast GJ; Schmier J
    Arzneimittelforschung; 1975 Jun; 25(6):891-6. PubMed ID: 51642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of molsidomine.
    Fiedler VB; Scholtholt J
    Arzneimittelforschung; 1978; 28(9):1605-12. PubMed ID: 582565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
    Torchiana ML; Lotti VJ; Clark CM; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):103-13. PubMed ID: 4148405
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic and hemodynamic influences on the rate of isovolumic left ventricular relaxation in the normal conscious dog.
    Karliner JS; LeWinter MM; Mahler F; Engler R; O'Rourke RA
    J Clin Invest; 1977 Sep; 60(3):511-21. PubMed ID: 893662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.